KindlyMD, Inc. (NASDAQ:NAKA) Short Interest Update

KindlyMD, Inc. (NASDAQ:NAKA) saw a large drop in short interest during the month of March. As of March 13th, there was short interest totaling 17,793,290 shares, a drop of 14.0% from the February 26th total of 20,681,566 shares. Approximately 4.3% of the shares of the company are short sold. Based on an average daily volume of 5,244,666 shares, the short-interest ratio is currently 3.4 days.

KindlyMD Price Performance

Shares of NASDAQ NAKA traded up $0.00 during trading hours on Tuesday, reaching $0.21. The stock had a trading volume of 970,278 shares, compared to its average volume of 5,244,755. The company has a market cap of $93.86 million, a price-to-earnings ratio of -0.19 and a beta of 31.40. KindlyMD has a twelve month low of $0.21 and a twelve month high of $34.77. The business’s fifty day moving average is $0.29 and its two-hundred day moving average is $0.57.

Hedge Funds Weigh In On KindlyMD

Hedge funds and other institutional investors have recently made changes to their positions in the business. Osaic Holdings Inc. acquired a new stake in shares of KindlyMD during the 2nd quarter valued at about $215,000. Vontobel Holding Ltd. acquired a new position in KindlyMD in the third quarter worth about $335,000. Dynamic Technology Lab Private Ltd acquired a new position in KindlyMD in the third quarter worth about $369,000. Geode Capital Management LLC lifted its stake in KindlyMD by 76.2% during the second quarter. Geode Capital Management LLC now owns 19,394 shares of the company’s stock worth $484,000 after purchasing an additional 8,386 shares during the period. Finally, Tower Research Capital LLC TRC boosted its holdings in KindlyMD by 1,638.4% during the third quarter. Tower Research Capital LLC TRC now owns 33,152 shares of the company’s stock valued at $827,000 after purchasing an additional 31,245 shares in the last quarter.

Analyst Upgrades and Downgrades

NAKA has been the topic of several research reports. B. Riley Financial dropped their price objective on shares of KindlyMD from $1.00 to $0.50 and set a “buy” rating on the stock in a report on Monday, February 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of KindlyMD in a research report on Friday. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $4.25.

KindlyMD Company Profile

Kindly MD, Inc (“KindlyMD” or “Kindly”) is a Utah company formed in 2019. KindlyMD is a healthcare data company, focused on holistic pain management and reducing the impact of the opioid epidemic. KindlyMD offers direct health care to patients integrating prescription medicine and behavioral health services to reduce opioid use in the chronic pain patient population. Kindly believes these methods will help prevent and reduce addiction and dependency on opiates. Our specialty outpatient clinical services are offered on a fee-for-service basis.